These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24992038)

  • 1. Cationic lipid-formulated DNA vaccine against hepatitis B virus: immunogenicity of MIDGE-Th1 vectors encoding small and large surface antigen in comparison to a licensed protein vaccine.
    Endmann A; Klünder K; Kapp K; Riede O; Oswald D; Talman EG; Schroff M; Kleuss C; Ruiters MH; Juhls C
    PLoS One; 2014; 9(7):e101715. PubMed ID: 24992038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of MIDGE-Th1 DNA vaccines with the cationic lipid SAINT-18: studies on formulation, biodistribution and vector clearance.
    Endmann A; Oswald D; Riede O; Talman EG; Vos RE; Schroff M; Kleuss C; Ruiters MH; Juhls C
    Vaccine; 2014 Jun; 32(27):3460-7. PubMed ID: 24681271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptide.
    Schirmbeck R; König-Merediz SA; Riedl P; Kwissa M; Sack F; Schroff M; Junghans C; Reimann J; Wittig B
    J Mol Med (Berl); 2001 Jun; 79(5-6):343-50. PubMed ID: 11485031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response induced by a linear DNA vector: influence of dose, formulation and route of injection.
    Endmann A; Baden M; Weisermann E; Kapp K; Schroff M; Kleuss C; Wittig B; Juhls C
    Vaccine; 2010 May; 28(21):3642-9. PubMed ID: 20362204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.
    Chow YH; Huang WL; Chi WK; Chu YD; Tao MH
    J Virol; 1997 Jan; 71(1):169-78. PubMed ID: 8985336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removing N-terminal sequences in pre-S1 domain enhanced antibody and B-cell responses by an HBV large surface antigen DNA vaccine.
    Ge G; Wang S; Han Y; Zhang C; Lu S; Huang Z
    PLoS One; 2012; 7(7):e41573. PubMed ID: 22844502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
    Zhou C; Peng G; Jin X; Tang J; Chen Z
    Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-mediated immunization to hepatitis B virus envelope proteins: preS antigen secretion enhances the humoral response.
    Prange R; Werr M
    Vaccine; 1999 Feb; 17(7-8):617-23. PubMed ID: 10067665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cationic domains in particle-forming and assembly-deficient HBV core antigens capture mammalian RNA that stimulates Th1-biased antibody responses by DNA vaccination.
    Krieger J; Stifter K; Riedl P; Schirmbeck R
    Sci Rep; 2018 Oct; 8(1):14660. PubMed ID: 30279478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphate.
    Wang S; Liu X; Fisher K; Smith JG; Chen F; Tobery TW; Ulmer JB; Evans RK; Caulfield MJ
    Vaccine; 2000 Jan; 18(13):1227-35. PubMed ID: 10649624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].
    Chen H; Deng Y; Tan W; Wang W; Yin X; Guan J; Wang W; Ruan L
    Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):74-8. PubMed ID: 20353095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
    Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
    J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection.
    Du DW; Jia ZS; Li GY; Zhou YY
    World J Gastroenterol; 2003 Jan; 9(1):108-11. PubMed ID: 12508362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Codelivery of a DNA vaccine and a protein vaccine with aluminum phosphate stimulates a potent and multivalent immune response.
    Kwissa M; Lindblad EB; Schirmbeck R; Reimann J
    J Mol Med (Berl); 2003 Aug; 81(8):502-10. PubMed ID: 12879151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice.
    Oka Y; Akbar SM; Horiike N; Joko K; Onji M
    Immunology; 2001 May; 103(1):90-7. PubMed ID: 11380696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic transfersomes based topical genetic vaccine against hepatitis B.
    Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
    Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coimmunization with RANTES plasmid polarized Th1 immune response against hepatitis B virus envelope via recruitment of dendritic cells.
    Ma K; Xu W; Shao X; Yanyue ; Hu L; Xu H; Yuan Z; Zheng X; Xiong S
    Antiviral Res; 2007 Nov; 76(2):140-9. PubMed ID: 17655942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
    Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
    Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved humoral and cellular immune responses against the gp120 V3 loop of HIV-1 following genetic immunization with a chimeric DNA vaccine encoding the V3 inserted into the hepatitis B surface antigen.
    Fomsgaard A; Nielsen HV; Bryder K; Nielsen C; Machuca R; Bruun L; Hansen J; Buus S
    Scand J Immunol; 1998 Apr; 47(4):289-95. PubMed ID: 9600309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
    Li X; Yang X; Li L; Liu H; Liu J
    Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.